DE3676104D1 - Benzanellierte heterocyclische verbindung. - Google Patents

Benzanellierte heterocyclische verbindung.

Info

Publication number
DE3676104D1
DE3676104D1 DE8686301710T DE3676104T DE3676104D1 DE 3676104 D1 DE3676104 D1 DE 3676104D1 DE 8686301710 T DE8686301710 T DE 8686301710T DE 3676104 T DE3676104 T DE 3676104T DE 3676104 D1 DE3676104 D1 DE 3676104D1
Authority
DE
Germany
Prior art keywords
compound
alkyl
agent
formula
heterocyclic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686301710T
Other languages
English (en)
Inventor
Ikuo Ueda
Youichi Shiokawa
Takashi Manabe
Yousuke Katsura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3676104D1 publication Critical patent/DE3676104D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE8686301710T 1985-03-26 1986-03-10 Benzanellierte heterocyclische verbindung. Expired - Fee Related DE3676104D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858507782A GB8507782D0 (en) 1985-03-26 1985-03-26 Benzene-fused heterocyclic compound

Publications (1)

Publication Number Publication Date
DE3676104D1 true DE3676104D1 (de) 1991-01-24

Family

ID=10576627

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301710T Expired - Fee Related DE3676104D1 (de) 1985-03-26 1986-03-10 Benzanellierte heterocyclische verbindung.

Country Status (15)

Country Link
US (1) US4692444A (de)
EP (1) EP0196803B1 (de)
JP (1) JPH0676414B2 (de)
CN (1) CN86101991A (de)
AT (1) ATE59043T1 (de)
AU (1) AU5478286A (de)
DE (1) DE3676104D1 (de)
DK (1) DK109786A (de)
ES (1) ES8800230A1 (de)
FI (1) FI860997A (de)
GB (1) GB8507782D0 (de)
GR (1) GR860739B (de)
HU (1) HU195511B (de)
NO (1) NO861220L (de)
ZA (1) ZA861733B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080439A1 (ja) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 三環性化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624102A (en) * 1969-05-21 1971-11-30 Warner Lambert Co Substituted benzopyranopyrazoles
US3816438A (en) * 1972-12-22 1974-06-11 Sandoz Ag 2h(1)-benzothiepino(5,4-c)-pyrazoles and(1)-benzothiopyrano(4,3-c)-pyrazoles
US3963740A (en) * 1973-07-16 1976-06-15 Parke, Davis & Company Benzo and benzothiopyranoindazole N-oxides
US4026899A (en) * 1974-09-20 1977-05-31 Parke, Davis & Company Benzo and benzothiopyranoindazole N-oxides
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
DE3003019A1 (de) * 1980-01-29 1981-07-30 Bayer Ag, 5090 Leverkusen N,n-dimethyl-o-(4,6-dihydro-2h-thieno (3,4-c) pyrazol-3-yl)-carbaminsaeure-ester sowie deren 5-oxide und 5,5-dioxide, verfahren zu deren herstellung und ihre verwendung in schaedlingsbekaempfungsmitteln

Also Published As

Publication number Publication date
FI860997A0 (fi) 1986-03-11
FI860997A (fi) 1986-09-27
GR860739B (en) 1986-07-18
JPS61233688A (ja) 1986-10-17
AU5478286A (en) 1986-10-02
ES8800230A1 (es) 1987-11-01
US4692444A (en) 1987-09-08
GB8507782D0 (en) 1985-05-01
ZA861733B (en) 1986-10-29
DK109786D0 (da) 1986-03-10
DK109786A (da) 1986-09-27
EP0196803B1 (de) 1990-12-12
HU195511B (en) 1988-05-30
EP0196803A2 (de) 1986-10-08
EP0196803A3 (en) 1988-01-07
NO861220L (no) 1986-09-29
CN86101991A (zh) 1986-10-08
ES553358A0 (es) 1987-11-01
HUT40801A (en) 1987-02-27
ATE59043T1 (de) 1990-12-15
JPH0676414B2 (ja) 1994-09-28

Similar Documents

Publication Publication Date Title
KR940007270B1 (en) Quinazoline derivatives
FI891176A0 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DE69817393D1 (de) Neue heterozyklische verbindungen
FI890689A (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
ATE89825T1 (de) Benzo-kondensierte heterocyclische verbindung.
DE3676104D1 (de) Benzanellierte heterocyclische verbindung.
FI895139A0 (fi) Pyrrolidinderivat.
DE69000806T2 (de) Indol-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee